MedTrace Logo

Tolerance to Residual Astigmatism in Eyes With Vivity®

NCT05392998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-03-18

Study results available
· View outcomes & findings →

Summary

Low amounts of postoperative residual astigmatism may worsen the visual performance of patients implanted with presbyopia- correcting intraocular lenses (IOLs). Although extended depth of focus (EDoF) IOLS have introduced optical improvements, it is important to determine the tolerance of these IOLs to postoperative astigmatism. This is important for an appropriate surgical planning.

Therefore, the aim of this study is to simulate and assess the impact of mild amounts of residual mixed astigmatisms with the axis oriented in different positions (vertical, oblique and horizontal) in eyes implanted with the Vivity® IOL.

Conditions

  • Lenses, Intraocular

Interventions

DEVICE

Cataract surgery with Vivity intraocular lens implantation

Cataract surgery with Vivity intraocular lens implantation

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Clínica Rementería

    lead OTHER

Principal Investigators

  • Laureano Rementeria-Capelo, MD · Clínica Rementería

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-16
Primary Completion
2022-03-09
Completion
2022-03-09
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05392998 on ClinicalTrials.gov